How does honey affect diabetics?

Checked on January 17, 2026
Disclaimer: Factually can make mistakes. Please verify important information or breaking news. Learn more.

Executive summary

Honey raises blood glucose—like all carbohydrates—so people with diabetes must treat it as a measured source of added sugar rather than a medicine; some short-term studies show smaller immediate blood‑sugar spikes from honey than from pure glucose or sucrose, but longer trials have found higher HbA1c with regular honey intake, so benefits are inconsistent and context dependent [1] [2] [3] [4]. Nutrition authorities and diabetes experts generally conclude there’s no clear advantage to routinely substituting honey for sugar in a diabetes eating plan; moderation and individualized monitoring are essential [5] [6].

1. How honey affects blood sugar in the short term

Multiple experimental and small clinical studies report that honey causes an immediate rise in blood glucose but often a smaller or shorter-lived spike than equivalent amounts of glucose or sucrose—honey’s glycemic index is typically reported around 50 versus about 80 for table sugar—meaning per gram honey on average raises blood sugar less quickly than white sugar, though it still raises it and must be counted as carbohydrate [1] [6] [7].

2. What longer trials and clinical endpoints show

Longer-duration trials and reviews paint a more cautious picture: randomized trials of weeks to months reported improvements in some lipids or body weight but also increases in HbA1c or fasting glucose in some cohorts who consumed honey regularly, and systematic reviews note that high intake may worsen glycemic control—so while short-term glucose excursions may sometimes be smaller, habitual consumption at higher doses has been associated with worse long-term measures of glycemia [3] [8] [4] [9].

3. Why honey’s impact can differ from plain sugar: composition and proposed mechanisms

Honey is a complex mix of fructose and glucose plus small amounts of minerals, polyphenols and other compounds; fructose has a much lower glycemic index than glucose and can blunt immediate blood‑glucose rises, and antioxidant or insulin‑modulating constituents have been hypothesized to improve metabolic markers in small studies or animal work—but human data are sparse and variable, so these mechanistic leads explain heterogeneity without proving clinically meaningful benefit for people with diabetes [10] [11] [4].

4. Practical implications for people with diabetes

Because honey is still a concentrated source of sugars and calories, guidance from clinical sources emphasizes moderation and individualized planning: count honey as carbohydrate, limit portion size, pair it with protein or fiber to slow absorption, monitor glucose responses after consumption, and consult clinicians before making it a routine substitute for other sweeteners—some experts say there’s no advantage to routinely swapping sugar for honey in a diabetes meal plan [1] [5] [12] [13].

5. Where reporting diverges and what remains uncertain

The literature contains conflicting signals—small lab and animal studies often show favorable metabolic effects while some human trials find higher HbA1c with regular honey use; meta‑analyses differ by included studies, honey type and dose, and most trials are small or short-term, so definitive claims—either that honey is a safe sweetener for all people with diabetes or that it is uniquely harmful—are not supported by strong large-scale randomized evidence [4] [8] [9]. Reporting and commercial sources sometimes overstate benefits (e.g., Manuka marketing) without acknowledging the demonstrated risk of glucose rises and HbA1c increases at higher intake; the conservative clinical stance is to treat honey as an occasional, measurable sugar rather than a therapeutic food [12] [5].

6. Bottom line for clinicians and patients

Honey can be used sparingly by some people with well‑controlled diabetes who understand carbohydrate counting and monitor post‑prandial responses, but it is not a harmless or superior alternative to other sugars for everyone; regular or high consumption has been linked to worse glycemic control in some trials, so clinical decisions should be individualized and informed by glucose monitoring and professional advice [1] [3] [4].

Want to dive deeper?
What does the 2022 meta-analysis of honey and fasting blood glucose actually conclude about different honey types?
How do fructose-containing sweeteners compare to glucose and sucrose for long-term HbA1c in type 2 diabetes?
What clinical guidance do diabetes associations give about using honey or other 'natural' sweeteners?